FORUM INSTITUT
FORUM · Institut für Management GmbH
Vangerowstraße 18
69115 Heidelberg
Email: service@forum-institut.de
Phone: +49 6221 500-500
Fax: +49 6221 500-505
Course Pharma - Marketing Authorisation in ASIA
Marketing Authorisation
in ASIA
China, Indonesia, Hong Kong, Singapore, Thailand,
Korea, Malaysia, The Philippines, Vietnam, Taiwan
2018-12-22 2019-10-24 Dorint Kongresshotel Friedrichsring 6 68161 Mannheim info.mannheim@dorint.com +49 621 1251-0 +49 621 1251-100

Marketing Authorisation in ASIA

China, Indonesia, Hong Kong, Singapore, Thailand, Korea, Malaysia, The Philippines, Vietnam, Taiwan

Basic and advanced know-how on the current regulatory framework of the various countries will be addressed in this course.
Topics
  • Current regulatory framework
  • ASEAN: Harmonisation of the Asian drug market?
  • China - guidelines and marketing authorisation
  • Marketing authorisation for NCEs and generics
  • Submission of variations and renewals
  • Communication with the authorities

This distinguishes our event

100 %
Overall impression: 100 % of the participants' feedback was very good or good (October 2018)
100 %
Course content: 100 % of the participants' feedback was very good or good (October 2018)
80%
Practical benefit: 80 % of the participants' feedback was very good or good (October 2018)

Aims and objectives

You are interested in receiving and maintaining a marketing authorisation in Asia? Then you shouldn't miss this seminar! After having completed this seminar you have an in-depth insight into the current regulatory framework of the various countries.

Two experts will give you valuable information regarding
  • dossier requirements
  • communication with the authorities
  • marketing authorisation procedures and
  • maintenance duties

and inform you about future developments in the ASEAN region. If you are in need of basic know-how, we recommend attending the introductory seminar on day one. Here you will be informed in detail about the various regions of Asia, including in-depth information on China and the ASEAN countries.

Who should attend
This seminar will be of benefit to all those working in the pharmaceutical industry and interested in marketing pharmaceuticals in Asia. Especially those working in regulatory affairs and business development will profit from the seminar.

Participants in need of basic know-how regarding the Asian market will especially benefit from the introductory seminar on day one.

This seminar is restricted to 20 participants.
Your speakers
Your speakers for all days
Dr. Alan A. Chalmers
Pharma International, Innovation Centre, SWITZERLAND

Dr. Mónica Dressler-Meyer
Consultant for Regulatory Affairs, Binningen, SWITZERLAND


Go forward

International events

Our international course portfolio

Are you interested in our international continuous education programme? We provide a variety of specialised courses for the healthcare industry.

Details

Abbreviations, Glossary

List of abbreviations

Many abbreviations for processes, documents and authorities, amongst others, are used in all regulatory areas. We have compiled the most important ones for you.

Our list of abbreviations can be freely downloaded here.

Details

More on our quality criteria

Quality guaranteed!

IMI (Innovative Medicines Initiative) defined quality criteria for professional training and education. We follow these criteria and, as a signatory, we are an active partner in further developing and optimising the quality standards.

An aggregate evaluation of participants' feedback on all FORUM's healthcare training courses (evaluation period from 10.2017 - 09.2018 produced a result of 1.6 (based on a school grading system of 1-6).

Details